Importantly, co-immunoprecipitation assays have identified a new AHI-1-BCR-ABL-JAK2 interaction complex at endogenous levels in CML cells [19]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.